World's Best Scientists 2026 revealed!
Silvia Fargion

Silvia Fargion

D-Index & Metrics

Medicine

D-Index
90
Citations
24982
World Ranking
12355
National Ranking
464

Overview

Silvia Fargion is affiliated with the University of Milan in Italy and has contributed extensively to the field of medicine, with a primary focus on hepatology, epidemiology, endocrinology, diabetes, and metabolism. Their research work spans various subfields, including physiology and surgery, reflecting a multidisciplinary approach to medical science.

Their publication record includes articles in several well-known venues, indicative of their research scope and collaboration networks. Frequent publication venues include:

  • Digestive and Liver Disease
  • Journal of Hepatology
  • International Journal of Molecular Sciences
  • Metabolism and Target Organ Damage
  • Current Pharmaceutical Design

Fargion's research topics focus significantly on liver-related diseases and metabolic conditions. Main topics covered in their publications include:

  • Liver Disease Diagnosis and Treatment
  • Diet, Metabolism, and Disease
  • Hepatitis C Virus Research
  • Liver Disease and Transplantation
  • Alcohol Consumption and Health Effects
  • Endoplasmic Reticulum Stress and Disease
  • Pancreatitis Pathology and Treatment

Their research collaboration network features frequent coauthors such as Anna Ludovica Fracanzani, Rosa Lombardi, Paola Dongiovanni, Annalisa Cespiati, and Giuseppina Pisano, showing ongoing teamwork in related medical and biochemical investigations.

Several recent papers highlight Fargion's research contributions over the past few years, including:

  • Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD, 2021, Journal of Hepatology
  • Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease, 2020, International Journal of Molecular Sciences
  • Dysmetabolic Hyperferritinemia and Dysmetabolic Iron Overload Syndrome (DIOS): Two Related Conditions or Different Entities?, 2020, Current Pharmaceutical Design
  • PD-1/PD-L1 Immuno-Mediated Therapy in NAFLD: Advantages and Obstacles in the Treatment of Advanced Disease, 2022, International Journal of Molecular Sciences
  • Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist, 2020, Digestive and Liver Disease

Fargion's research emphasizes the interplay between genetic factors, metabolic conditions, and liver diseases, delving into issues such as iron metabolism disorders and immune-mediated therapies for liver disorders. The diversity of research venues and coauthors supports a broad engagement with the medical research community, particularly in hepatology and metabolic disease fields.

Best Publications

  • Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    Vlad Ratziu;Vlad Ratziu;Stephen A. Harrison;Sven Francque;Pierre Bedossa

  • Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.

    Anna Ludovica Fracanzani;Luca Valenti;Elisabetta Bugianesi;Marco Andreoletti

  • Homozygosity for the patatin-like phospholipase-3/adiponutrin i148m polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease

    Luca Valenti;Ahmad Al-Serri;Ann K. Daly;Enrico Galmozzi

  • The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

    Rosellina Margherita Mancina;Paola Dongiovanni;Salvatore Petta;Piero Pingitore

  • Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

    Paola Dongiovanni;Salvatore Petta;Cristina Maglio;Anna Ludovica Fracanzani

  • Statin use and non-alcoholic steatohepatitis in at risk individuals

    Paola Dongiovanni;Salvatore Petta;Ville Mannisto;Rosellina Margherita Mancina

  • Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease

    Luca Valenti;Anna Ludovica Fracanzani;Paola Dongiovanni;Gennaro Santorelli

  • Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target

    Paola Dongiovanni;Anna Ludovica Fracanzani;Silvia Fargion;Luca Valenti

  • PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells

    Carlo Pirazzi;Luca Valenti;Benedetta Maria Motta;Piero Pingitore

  • Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.

    Silvia Fargion;Alberto Piperno;Maria Domenica Cappellini;Maurizio Sampietro

  • Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.

    Luca Valenti;Anna Ludovica Fracanzani;Paola Dongiovanni;Elisabetta Bugianesi

  • Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.

    Silvia Fargion;Michela Mattioli;Anna Ludovica Fracanzani;Maurizio Sampietro

  • HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.

    Luca Valenti;Anna Ludovica Fracanzani;Elisabetta Bugianesi;Paola Dongiovanni

  • I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease

    Luca Valenti;Anna Alisi;Enrico Galmozzi;Andrea Bartuli

  • Carotid Artery Intima-media Thickness in Nonalcoholic Fatty Liver Disease

    Anna Ludovica Fracanzani;Larry Burdick;Sara Raselli;Paola Pedotti

  • Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non–iron-related chronic liver disease

    Anna Ludovica Fracanzani;Dario Conte;Mirella Fraquelli;Emanuela Taioli

  • Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver.

    P Dongiovanni;S Stender;A Pietrelli;Rosellina Margherita Mancina

  • Patatin‐Like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C

    Luca Valenti;MariaGrazia Rumi;Enrico Galmozzi;Alessio Aghemo

  • Heterogeneity of hemochromatosis in Italy

    Alberto Piperno;Maurizio Sampietro;Antonello Pietrangelo;Cristina Arosio

  • Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee.

    P. Loria;L. E. Adinolfi;S. Bellentani;E. Bugianesi

Frequent Co-Authors

Luca Valenti
Luca Valenti University of Milan
Anna Ludovica Fracanzani
Anna Ludovica Fracanzani University of Milan
Maria Domenica Cappellini
Maria Domenica Cappellini University of Milan
Elisabetta Bugianesi
Elisabetta Bugianesi University of Turin
Antonio Craxì
Antonio Craxì University of Palermo
Salvatore Petta
Salvatore Petta University of Palermo
Stefano Romeo
Stefano Romeo University of Gothenburg
Pietro Lampertico
Pietro Lampertico University of Milan
María I. Colombo
María I. Colombo National University of Cuyo
Valerio Nobili
Valerio Nobili Sapienza University of Rome

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring healthcare professionals have more options than ever to advance their education online. Whether you’re interested in direct patient care or the business side of medicine, there are online degrees designed to match your goals and schedule.

For nurses aiming to specialize, psych nurse practitioner programs offer a focused pathway into mental health care. These programs are designed for working nurses who want to quickly advance their credentials and help address the growing demand for mental health professionals.

Those looking for an affordable route into healthcare might consider pursuing the cheapest online health science degree. This option opens the door to entry-level healthcare jobs and can be a stepping stone to advanced degrees.

If you plan to move into management or leadership roles, understanding the cost of mha degree programs can help you select an affordable master’s program in healthcare administration.

Nurses seeking the highest levels of clinical practice should compare the cheapest online dnp programs. These programs provide a pathway to leadership in advanced nursing practice and clinical research.

Best Scientists Citing Silvia Fargion

Trending Scientists